SCHEMBL22258679

SCHEMBL22258679

Clc1nc(-c2ccccc2)c2ccc3sc4cc5ccccc5cc4c3c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.41
ALDH1A1 P00352 7/20 0.41
MAPT P10636 4/20 0.41
LMNA P02545 2/20 0.41
HPGD P15428 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GLA P06280 1/20 0.40
KMT2A Q03164 4/20 0.37
OPRK1 P41145 1/20 0.37
MEN1 O00255 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ESR1 P03372 3/20 0.34
ESR2 Q92731 3/20 0.34
MAPK1 P28482 1/20 0.32
NPSR1 Q6W5P4 2/20 0.31
CASP1 P29466 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MAT2A P31153 1/20 0.31
GAA P10253 1/20 0.31
ADORA1 P30542 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22258322 0.90 RPA1 (0.34) KDM4EALDH1A1MAPTLMNAHPGD
SCHEMBL19758804 0.85 KDM4E (0.42) KDM4EALDH1A1MAPTLMNAHPGD
SCHEMBL22258681 0.84 CYP1A1 (0.33) KDM4EALDH1A1MAPTHSD17B10
SCHEMBL22258321 0.84
SCHEMBL22258603 0.84 MEN1 (0.38) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL22258684 0.83 LMNA (0.41) KDM4EALDH1A1MAPTLMNAHPGD
SCHEMBL22258673 0.83 CYP1A1 (0.41) KDM4EALDH1A1MAPTLMNAHPGD
SCHEMBL22258715 0.81 WHR1 (0.34) HPGDKMT2AMEN1ADORA1
SCHEMBL22258717 0.81 LIMK1 (0.34) HPGDKMT2AMEN1
SCHEMBL18688214 0.79 KDM4E (0.44) KDM4EALDH1A1MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11211568-B2 Compound for organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2021-12-28 US disclosed
US-20200235311-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11211568-B2 Compound for organic electroluminescence device using the same OR10J3, PIEZO1, ICMT KDM4E 1352/4885ALDH1A1 353/4885MAPT 686/4885
US-20200235311-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, PIEZO1, ICMT KDM4E 1352/4885ALDH1A1 353/4885MAPT 686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.